Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry.
Kada Mohammed S, Dabakuyo Yonli TS, Desmoulins I, Manguem Kamga A, Jankowski C, Padeano MM, Loustalot C, Costaz H, Causeret S, Peignaux K, Rouffiac M, Coutant C, Arnould L, Ladoire S. Kada Mohammed S, et al. Among authors: loustalot c. Breast Cancer Res Treat. 2023 Jan;197(2):377-385. doi: 10.1007/s10549-022-06807-w. Epub 2022 Nov 23. Breast Cancer Res Treat. 2023. PMID: 36417042 Free PMC article.
Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.
Costaz H, Boulle D, Bertaut A, Rouffiac M, Beltjens F, Desmoulins I, Peignaux K, Ladoire S, Causeret S, Loustalot C, Padeano MM, Vincent L, Jankowski C, Arnould L, Coutant C. Costaz H, et al. Among authors: loustalot c. Bull Cancer. 2022 Mar;109(3):268-279. doi: 10.1016/j.bulcan.2021.09.018. Epub 2021 Nov 24. Bull Cancer. 2022. PMID: 34838310
Impact of sentinel node biopsy on long-term quality of life in breast cancer patients.
De Gournay E, Guyomard A, Coutant C, Boulet S, Arveux P, Causeret S, Gouy S, Padeano MM, Loustalot C, Sauzedde JM, Smail M, Combier JP, Chevillote P, Rosburger C, Bonnetain F, Fraisse J, Dabakuyo-Yonli TS. De Gournay E, et al. Among authors: loustalot c. Br J Cancer. 2013 Nov 26;109(11):2783-91. doi: 10.1038/bjc.2013.658. Epub 2013 Oct 29. Br J Cancer. 2013. PMID: 24169352 Free PMC article. Clinical Trial.
Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.
Bergeron A, MacGrogan G, Bertaut A, Ladoire S, Arveux P, Desmoulins I, Bonnefoi H, Loustalot C, Auriol S, Beltjens F, Degrolard-Courcet E, Charon-Barra C, Richard C, Boidot R, Arnould L. Bergeron A, et al. Among authors: loustalot c. Mod Pathol. 2021 Jul;34(7):1282-1296. doi: 10.1038/s41379-021-00742-9. Epub 2021 Mar 22. Mod Pathol. 2021. PMID: 33753865 Free PMC article.
The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
Eliade M, Skrzypski J, Baurand A, Jacquot C, Bertolone G, Loustalot C, Coutant C, Guy F, Fumoleau P, Duffourd Y, Arnould L, Delignette A, Padéano MM, Lepage C, Raichon-Patru G, Boudrant A, Bône-Lépinoy MC, Villing AL, Charpin A, Peignaux K, Chevrier S, Vegran F, Ghiringhelli F, Boidot R, Sevenet N, Lizard S, Faivre L. Eliade M, et al. Among authors: loustalot c. Oncotarget. 2017 Jan 10;8(2):1957-1971. doi: 10.18632/oncotarget.12699. Oncotarget. 2017. PMID: 27779110 Free PMC article.
38 results